Transverse Medical Inc. (TMI) is developing the POINT-GUARD™ Dynamic Cerebral Embolic Protection (CEP) medical device to address the devastating and costly problem of stroke during the large and growing number of heart valve procedures that occur annually around the world, such as Transcatheter Aortic Valve Replacement (TAVR).

Medical Devices

Transverse Medical

Eric Goslau

Michael Reardon

Daniel Estay

The Leadership Team at Transverse Medical is responsible for guiding the strategic vision and operational direction of the company. This team, comprised of co-founders and executives, focuses on driving innovation in the development of the POINT-GUARD™ device, fostering partnerships, ensuring regulatory compliance, and positioning the company for growth in the medical device market while addressing critical healthcare challenges related to stroke prevention during heart valve procedures.

Leadership Team

About

Team members

Other teams at Transverse Medical

Clinical Affairs Team